Market Place
Sourcing Support
All News #Library
Biotech
FDA Approves HDT Bio`s HDT-321 for Tick-Borne Disease Prevention
19 Sep 2025 //
PR NEWSWIRE
MalarVx Licenses HDT`s repRNA/LION For Malaria Vaccine Development
16 Jan 2025 //
PR NEWSWIRE
HDT Bio To Spearhead RNA Vaccine Development For Pandemic Preparedness
17 Sep 2024 //
PR NEWSWIRE
HDT Bio Publishes Peer-Reviewed Article On Enterovirus D68 Vaccine
07 Aug 2024 //
PR NEWSWIRE
Emcure, Gennova settle litigation with HDT, ink pact to develop mRNAvaccines
23 May 2024 //
MONEYCONROL
HDT Bio Receives $749,000 EZBAA Contract
23 Jan 2024 //
PR NEWSWIRE
HDT Bio Publishes Study Demonstrating Advantages of repRNA and LION Tech
24 Jul 2023 //
PR NEWSWIRE
HDT Bio Publishes Study Demonstrating Robust Immunological Response
24 Mar 2023 //
PR NEWSWIRE
Copyright © 2026 LePro PharmaCompass OPC Private Limited, All rights reserved.